LakeShore Biopharma Co., Ltd (LSB)

0.5468 -0.0192 (-3.39%) At close: 04:00PM EDT

LakeShore Biopharma Co., Ltd

Building No. 2
38 Yongda Road Daxing Biomedical Industry Park Daxing District
Beijing 102629
China
86 10 8920 2086
https://www.ysbiopharm.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 773

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Gang Li	Head of Marketing & Sales	N/A	N/A	1982
Dr. Yuan Liu Ph.D.	Head of Vaccine Research	N/A	N/A	1987
Mr. Dave Chenn	Co-CEO & Chairperson of the Board	N/A	N/A	N/A
Dr. Hui Shao C.F.A., M.B.A., Ph.D.	Co-Chief Executive Officer, President, Chief Business Officer & Executive Director	N/A	N/A	1968
Mr. Wang Xu	Chief Operation Officer	N/A	N/A	N/A
Dr. Zenaida Reynoso Mojares M.D.	Chief Medical Officer	N/A	N/A	1959

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Corporate governance

LakeShore Biopharma Co., Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.